Global Response To Swine Flu Unprecedented; Vaccine Makers Ready To Switch
This article was originally published in PharmAsia News
HONG KONG - For the first time in history, the emergence and spread of a pandemic is being tracked globally and in real time. The result has been a coordinated global response from countries both affected and unaffected as well as participation from the private sector
You may also be interested in...
SEOUL - With global health authorities warning of the possibility of the swine flu blooming into a pandemic, Korea's Ministry for Health, Welfare and Family Affairs has begun to cover Roche's Tamiflu (oseltamivir) and GlaxoSmithKline's Relenza (zanamivir) under the National Medical Insurance System for those likely exposed to the swine flu
MUMBAI - Known for supplies of cheap anti-retroviral drugs to major African nations, Indian drug maker Cipla has offered to make available 1.5 million dosage of Tamiflu generic oseltamivir within the next 4 to 6 weeks to control the further spread of the dreaded swine flu
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).